SCHEMBL14797017

SCHEMBL14797017

Cc1ccc(Oc2ncc3nc(-c4cc(C)c(OCC(=O)O)c(C)c4)oc3n2)cn1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.73
PPARG P37231 3/20 0.36
PPARA Q07869 2/20 0.36
PTPN1 P18031 2/20 0.35
KDM4E B2RXH2 3/20 0.34
HTT P42858 2/20 0.34
PKM P14618 1/20 0.34
PPARD Q03181 7/20 0.34
FFAR1 O14842 1/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
CSNK2A1 P68400 1/20 0.33
THRA P10827 1/20 0.33
THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2223316 0.90 S1PR1 (0.75) S1PR1PPARGPPARAPTPN1KDM4E
SCHEMBL2223368 0.89 S1PR1 (0.83) S1PR1PPARGPPARAPTPN1KDM4E
SCHEMBL2222062 0.89 S1PR1 (0.82) S1PR1PPARGPPARAPTPN1PPARD
SCHEMBL2222826 0.89 S1PR1 (0.73) S1PR1PPARGPPARAPTPN1PPARD
SCHEMBL14797145 0.88 S1PR1 (0.77) S1PR1PPARGPPARAPTPN1KDM4E
SCHEMBL14797053 0.87 S1PR1 (0.76) S1PR1PPARGPPARAPTPN1PPARD
SCHEMBL14797191 0.87 S1PR1 (0.79) S1PR1PPARGPPARAPTPN1KDM4E
SCHEMBL14797164 0.87 S1PR1 (0.73) S1PR1PPARGPPARAPTPN1PPARD
SCHEMBL14797116 0.87 S1PR1 (0.76) S1PR1PPARGPPARAPTPN1PPARD
SCHEMBL14797067 0.86 S1PR1 (0.70) S1PR1PPARGPPARAPTPN1PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846692-B2 Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring SANOFI (FR) 2014-09-30 US disclosed
US-20130079358-A1 CARBOXYLIC ACID DERIVATIVES HAVING A 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING SANOFI (FR) 2013-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130079358-A1 CARBOXYLIC ACID DERIVATIVES HAVING A 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING OXGR1, EDNRA, EDF1 S1PR1 129/4885PPARG 334/4885PPARA 432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.